Managing risk of surgical procedures in pediatric transplant recipients taking mTOR inhibitors: What is the optimal strategy?

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3046|22|1|petr.13136-petr.13136

ISSN： 1397-3142

Source： PEDIATRIC TRANSPLANTATION, Vol.22, Iss.1, 2018-02, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Safety of mTOR inhibitor continuation in pediatric heart transplant recipients undergoing surgical procedures

By  

PEDIATRIC TRANSPLANTATION, Vol. 22, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bullous pemphigoid induced by m‐TOR inhibitors in renal transplant recipients

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 8, 2015-08 ,pp. : 1626-1630

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictive factors of allosensitization in renal transplant patients switched from calcineurin to mTOR inhibitors

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 27, Iss. 8, 2014-08 ,pp. : 847-856

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bronchoscopic procedures and lung biopsies in pediatric lung transplant recipients

By  

PEDIATRIC PULMONOLOGY, Vol. 50, Iss. 12, 2015-12 ,pp. : 1406-1419

John Wiley & Sons Inc

Access to resources Recommend Favorite

mTOR inhibitors in renal cell carcinoma

By Battelli Chiara   Cho Daniel C  

Therapy, Vol. 8, Iss. 4, 2011-07 ,pp. : 359-367

Future Medicine

Access to resources Recommend Favorite